Search research articles
Contact Us
Filters
Showing results (141-150 of 312) with videos related to
Page
of 32
Sort By:
Neuron
|
March 13, 2010
Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence
F Woodward Hopf, M Scott Bowers, Shao-Ju Chang, et al.
Annals of Vascular Surgery
|
April 17, 2002
Utility of intraoperative transesophageal echocardiography during endovascular stent-graft repair of acute thoracic aortic dissection
Jose A Gonzalez-Fajardo, Vicente Gutierrez, Jose A San Roman, et al.
Onkologie
|
June 19, 2013
Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II Trials
Pilar García Alfonso, Andrés Muñoz Martin, Sonsoles Alvarez Suarez, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2020
Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes
Javier Arranz-Nicolás, Miguel Martin-Salgado, Cristina Rodríguez-Rodríguez, et al.
Vaccines
|
January 26, 2024
The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios
Victor Sanchez-Merino, Miguel Martin-Serrano, Manuela Beltran, et al.
Journal of Autism and Developmental Disorders
|
September 17, 2015
Brief Report: Translation and Adaptation of the Theory of Mind Inventory to Spanish
Elena Pujals, Santiago Batlle, Ester Camprodon, et al.
Lupus Science & Medicine
|
December 13, 2018
Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres
Chiara Tani, Elena Elefante, Miguel Martin-Cascón, et al.
NPJ Breast Cancer
|
June 23, 2021
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
Stephen Johnston, Joyce O'Shaughnessy, Miguel Martin, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2021
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
Javier Arranz-Nicolás, Miguel Martin-Salgado, Irene Adán-Barrientos, et al.
Breast Cancer Research and Treatment
|
July 13, 2022
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancer
Erika Hamilton, Javier Cortes, Ozgur Ozyilkan, et al.
Page
of 32
Search research articles
Search
Showing results (141-150 of 312) with videos related to
Sort By:
Page
of 32
Neuron
|
March 13, 2010
Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence
F Woodward Hopf, M Scott Bowers, Shao-Ju Chang, et al.
Annals of Vascular Surgery
|
April 17, 2002
Utility of intraoperative transesophageal echocardiography during endovascular stent-graft repair of acute thoracic aortic dissection
Jose A Gonzalez-Fajardo, Vicente Gutierrez, Jose A San Roman, et al.
Onkologie
|
June 19, 2013
Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II Trials
Pilar García Alfonso, Andrés Muñoz Martin, Sonsoles Alvarez Suarez, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2020
Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes
Javier Arranz-Nicolás, Miguel Martin-Salgado, Cristina Rodríguez-Rodríguez, et al.
Vaccines
|
January 26, 2024
The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios
Victor Sanchez-Merino, Miguel Martin-Serrano, Manuela Beltran, et al.
Journal of Autism and Developmental Disorders
|
September 17, 2015
Brief Report: Translation and Adaptation of the Theory of Mind Inventory to Spanish
Elena Pujals, Santiago Batlle, Ester Camprodon, et al.
Lupus Science & Medicine
|
December 13, 2018
Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres
Chiara Tani, Elena Elefante, Miguel Martin-Cascón, et al.
NPJ Breast Cancer
|
June 23, 2021
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
Stephen Johnston, Joyce O'Shaughnessy, Miguel Martin, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2021
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
Javier Arranz-Nicolás, Miguel Martin-Salgado, Irene Adán-Barrientos, et al.
Breast Cancer Research and Treatment
|
July 13, 2022
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancer
Erika Hamilton, Javier Cortes, Ozgur Ozyilkan, et al.
Page
of 32